Acorda Therapeutics, Inc. (ACORQ)

Acorda Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	0	19	19	27	33	98
Market Cap Growth	15.06%	0.47%	-30.29%	-19.10%	-66.22%	-86.76%
Enterprise Value	187	172	192	187	244	255
Last Close Price	0.01	15.09	15.33	47.80	82.81	244.80
Debt / Equity Ratio	-1.05	-1.21	1.85	1.29	1.16	0.88
Debt / EBITDA Ratio	85.85	18.40	-	-	-	-
Debt / FCF Ratio	-7.15	-13.40	-8.21	-4.71	-4.21	-1.25
Asset Turnover	0.51	0.47	0.28	0.24	0.21	0.18
Inventory Turnover	1.48	1.41	2.29	2.14	2.08	3.45
Quick Ratio	0.08	0.21	1.35	1.16	0.67	1.71
Current Ratio	0.22	0.33	2.16	1.89	1.61	2.33
Return on Equity (ROE)	-	-	-53.86%	-53.43%	-36.30%	-59.16%
Return on Assets (ROA)	-6.59%	-5.77%	-6.09%	-8.19%	-7.55%	-6.94%
Return on Capital (ROIC)	-11.39%	-9.71%	-8.46%	-10.37%	-9.85%	-9.28%
Buyback Yield / Dilution	-7.45%	-22.85%	-90.38%	-31.38%	-1.98%	-0.47%
Total Shareholder Return	-7.45%	-22.85%	-90.38%	-31.38%	-1.98%	-0.47%

Source: S&P Capital IQ. Standard template. Financial Sources.